NewAmsterdam Pharma Company N.V. Operating Lease, Liability, Noncurrent
NewAmsterdam Pharma Company N.V. (NAMS) had Operating Lease, Liability, Noncurrent of $56.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability, Noncurrent $56.00K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $66.00K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $85.00K.
- 2025-06-30: Operating Lease, Liability, Noncurrent $103.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $56.00K 10-Q · filed 2026-08-05 |
| 2025-12-31 | $66.00K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $85.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $103.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $137.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $202.00K 10-K · filed 2026-02-18 |
| 2024-09-30 | $266.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $328.00K 10-Q · filed 2024-08-07 |
| 2022-12-31 | $60.00K 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |